Angiotensin II receptor antagonists (ARBs): psoriasis

首页> 外文期刊>Prescrire international >Angiotensin II receptor antagonists (ARBs): psoriasis

【24h】

Angiotensin II receptor antagonists (ARBs): psoriasis

机译：血管紧张素II受体拮抗剂（ARBS）：牛皮癣

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The Reims (France) regional pharmaco- vigilance centre analysed reports of psoriasis attributed to sartans (ARBs) and recorded in the French pharmacovigilance database up to February 2016 (1). Losartan was the first sartan to be marketed in France, in the mid-1990s (2). 89 reports of psoriasis were analysed in patients aged 29 to 90 years (66 years on average), with slightly more men than women (1). Most often, the disorders occurred during the first year of exposure to the sartan, and in two-thirds of patients, they regressed after stopping the drug. A dispro-portionality analysis revealed a greater proportion of reports of psoriasis with several sartans than with the other drugs included in the database (1).

机译：Reims（法国）区域药物警察中心分析了牛皮癣的报道，归因于SARTANS（ARB），并在2016年2月的法国药物事故数据库中记录（1）。 Losartan是20世纪90年代中期（2）的第一个在法国销售的Sartan。 89例牛皮癣报告分析了29至90岁（平均66岁）的患者，比女性更长（1）。最常见的是，障碍发生在暴露于沙坦的第一年，以及三分之二的患者中，它们在停止药物后回归。 DATPRO分界分析显示了牛皮癣的牛皮癣报告，而不是数据库（1）中包含的其他药物。

著录项

来源
《Prescrire international》 |2019年第204期|共1页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Reciprocal Roles of Angiotensin II and Angiotensin II Receptors Blockade (ARB) in Regulating Cbfa1/RANKL via cAMP Signaling Pathway: Possible Mechanism for Hypertension-Related Osteoporosis and Antagonistic Effect of ARB on Hypertension-Related Osteoporosis [J] . Ji-Yao Li, Xiao-Xu Guan, Yi Zhou International Journal of Molecular Sciences . 2011,第7期

机译：血管紧张素II和血管紧张素II受体阻滞剂（ARB）通过cAMP信号通路调节Cbfa1 / RANKL的相互作用：高血压相关性骨质疏松的可能机制和ARB对高血压相关性骨质疏松的拮抗作用
2. Angiotensin II receptor antagonists (ARBs): psoriasis [J] . Prescrire international . 2019,第204期

机译：血管紧张素II受体拮抗剂（ARBS）：牛皮癣
3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). [J] . Ogawa H, Kim Mitsuyama S, Jinnouchi T Hypertension research: Official journal of the Japanese Society of Hypertension . 2009,第7期

机译：OlmeSartan和钙拮抗剂随机研究（OSCAR）的基本原理，设计和患者基线特征：一项针对日本老年人的大剂量血管紧张素II受体阻滞剂（ARB）单药治疗和ARB与钙通道阻滞剂联合治疗之间心血管事件发生率的比较研究高危高血压患者（ClinicalTrials。gov No. NCT00134160）。
4. Biological evaluation of a novel angiotensin II AT_1 receptor antagonist with anti-hypertensive and anti-tumor effects [C] . Yajing Da, Zhilong Chen International Conference on Chemical Engineering, Metallurgical Engineering and Metallic Materials . 2013

机译：新型血管紧张素II AT_1受体拮抗剂与抗高血压和抗肿瘤作用的生物学评价
5. Utilization of Vasopressin as a First Line Response to Perioperative Hypotension in the Patient on Angiotensin Receptor Antagonists and Angiotensin Converting Enzyme Inhibitors [D] . Buckley, Emily A. 2015

机译：利用血管加压素作为对围手术期低血压患者的血管紧张素受体拮抗剂和血管紧张素转化酶抑制剂的一线反应
6. Reciprocal Roles of Angiotensin II and Angiotensin II Receptors Blockade (ARB) in Regulating Cbfa1/RANKL via cAMP Signaling Pathway: Possible Mechanism for Hypertension-Related Osteoporosis and Antagonistic Effect of ARB on Hypertension-Related Osteoporosis [O] . Xiao-Xu Guan, Yi Zhou, Ji-Yao Li 2011

机译：血管紧张素II和血管紧张素II受体阻滞剂（ARB）通过cAMP信号通路调节Cbfa1 / RANKL的相互作用：高血压相关性骨质疏松症的可能机制和ARB对高血压相关性骨质疏松症的拮抗作用
7. Reciprocal Roles of Angiotensin II and Angiotensin II Receptors Blockade (ARB) in Regulating Cbfa1/RANKL via cAMP Signaling Pathway: Possible Mechanism for Hypertension-Related Osteoporosis and Antagonistic Effect of ARB on Hypertension-Related Osteoporosis [O] . Ji-Yao Li, Yi Zhou, Xiao-Xu Guan 2011

机译：血管紧张素II和血管紧张素II受体阻滞剂（ARB）通过cAMP信号通路调节Cbfa1 / RANKL的相互作用：高血压相关性骨质疏松症的可能机制和ARB对高血压相关性骨质疏松症的拮抗作用
8. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors (ACEls) and Angiotensin II Receptor Antagonists (ARBs) for Treating Essential Hypertension. Comparative Effectiveness Review, Number 10 [R] . Matchar, D. B., McCrory, D. C., Orlando, L. A., 2007

机译：血管紧张素转换酶抑制剂（aCEls）和血管紧张素II受体拮抗剂（aRBs）治疗原发性高血压的疗效比较。比较效力评估，第10号

Angiotensin II receptor antagonists (ARBs): psoriasis

摘要

著录项

相似文献

相关主题

期刊订阅